Publications by authors named "Todd Hembrough"

Claim this Profile
T
Targeting Aggressive B-cell Lymphomas through Pharmacological Activation of the Mitochondrial Protease OMA1.
Adrian Schwarzer, Matheus Oliveira, Marc-Jens Kleppa, Scott D Slattery, Andy Anantha, Todd Hembrough

Mol Cancer Ther· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative Multiplexed Proteomics Could Assist Therapeutic Decision Making in Non-Small Cell Lung Cancer Patients with Ambiguous ALK Test Results.
Ho Jung An, Eunkyung An, Shahrooz Rabizadeh, Wei-Li Liao, Jon Burrows, Todd Hembrough

Cancers (Basel)· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of high TUBB3 with resistance to adjuvant docetaxel-based chemotherapy in gastric cancer: translational study of ITACA-S.
Maria Di Bartolomeo, Alessandra Raimondi, Fabiola Cecchi, Daniel V T Catenacci, Sarit Schwartz, Todd A Hembrough

Tumori· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Exon 14-altered Lung Cancers and MET Inhibitor Resistance.
Robin Guo, Michael Offin, A Rose Brannon, Jason Chang, Andrew Chow, Todd Hembrough

Clin Cancer Res· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic and Predictive Impact of Circulating Tumor DNA in Patients with Advanced Cancers Treated with Immune Checkpoint Blockade.
Qu Zhang, Jia Luo, Song Wu, Han Si, Chen Gao, Todd Hembrough

Cancer Discov· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High throughput profiling of undifferentiated pleomorphic sarcomas identifies two main subgroups with distinct immune profile, clinical outcome and sensitivity to targeted therapies.
Maud Toulmonde, Carlo Lucchesi, Stéphanie Verbeke, Amandine Crombe, Julien Adam, Todd Hembrough

EBioMedicine· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
STK11 (LKB1) mutations in metastatic NSCLC: Prognostic value in the real world.
Norah J Shire, Alyssa B Klein, Asieh Golozar, Jenna M Collins, Kathy H Fraeman, Todd Hembrough

PLoS One· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Overcoming hypoxia-induced functional suppression of NK cells.
Kristen Solocinski, Michelle R Padget, Kellsye P Fabian, Benjamin Wolfson, Fabiola Cecchi, Todd Hembrough

J Immunother Cancer· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterization of MGMT and EGFR protein expression in glioblastoma and association with survival.
Lauren R Schaff, Dongyao Yan, Sheeno Thyparambil, Yuan Tian, Fabiola Cecchi, Todd Hembrough

J Neurooncol· January 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Translation and evaluation of a pre-clinical 5-protein response prediction signature in a breast cancer phase Ib clinical trial.
Axel Ducret, Ian James, Sabine Wilson, Martina Feilke, Andreas Tebbe, Todd Hembrough

PLoS One· December 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pazopanib or methotrexate-vinblastine combination chemotherapy in adult patients with progressive desmoid tumours (DESMOPAZ): a non-comparative, randomised, open-label, multicentre, phase 2 study.
Maud Toulmonde, Marina Pulido, Isabelle Ray-Coquard, Thierry Andre, Nicolas Isambert, Todd Hembrough

Lancet Oncol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted multiplex proteomics for molecular prescreening and biomarker discovery in metastatic colorectal cancer.
Garazi Serna, Fiorella Ruiz-Pace, Fabiola Cecchi, Roberta Fasani, Jose Jimenez, Todd Hembrough

Sci Rep· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
and Amplifications Determine Response to HER2 Inhibition in -Amplified Esophagogastric Cancer.
Francisco Sanchez-Vega, Jaclyn F Hechtman, Pau Castel, Geoffrey Y Ku, Yaelle Tuvy, Todd Hembrough

Cancer Discov· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Data-Independent Acquisition Mass Spectrometry To Quantify Protein Levels in FFPE Tumor Biopsies for Molecular Diagnostics.
Yeoun Jin Kim, Steve M M Sweet, Jarrett D Egertson, Andrew J Sedgewick, Sunghee Woo, Todd Hembrough

J Proteome Res· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining the selection of patients with metastatic colorectal cancer for treatment with temozolomide using proteomic analysis of O6-methylguanine-DNA-methyltransferase.
Sarit Schwartz, Chris Szeto, Yuan Tian, Fabiola Cecchi, Salvatore Corallo, Todd Hembrough

Eur J Cancer· January 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalized therapy based on sequential molecular analysis leads to 30 months of survival in a patient with diffuse unresectable gastric linitis plastica.
Linda Mahjoubi, Fabiola Cecchi, Christophe Massard, Fabio Calabro, Anas Gazzah, Todd Hembrough

Tumori· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exceptional responses to pertuzumab, trastuzumab, and docetaxel in human epidermal growth factor receptor-2 high expressing salivary duct carcinomas.
Jong Chul Park, T Martin Ma, Lisa Rooper, Todd Hembrough, Robert D Foss

Head Neck· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted data-independent acquisition for mass spectrometric detection of RAS mutations in formalin-fixed, paraffin-embedded tumor biopsies.
Yeoun Jin Kim, Andrew G Chambers, Fabiola Cecchi, Todd Hembrough

J Proteomics· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Gabrielle S Wong, Jin Zhou, Jie Bin Liu, Zhong Wu, Xinsen Xu, Todd Hembrough

Nat Med· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ado-Trastuzumab Emtansine for Patients With HER2-Mutant Lung Cancers: Results From a Phase II Basket Trial.
Bob T Li, Ronglai Shen, Darren Buonocore, Zachary T Olah, Ai Ni, Todd Hembrough

J Clin Oncol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting wild-type KRAS-amplified gastroesophageal cancer through combined MEK and SHP2 inhibition.
Gabrielle S Wong, Jin Zhou, Jie Bin Liu, Zhong Wu, Xinsen Xu, Todd Hembrough

Nat Med· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeted Therapies for Targeted Populations: Anti-EGFR Treatment for -Amplified Gastroesophageal Adenocarcinoma.
Steven B Maron, Lindsay Alpert, Heewon A Kwak, Samantha Lomnicki, Leah Chase, Todd Hembrough

Cancer Discov· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An approach to suppress the evolution of resistance in BRAF-mutant cancer.
Yaohua Xue, Luciano Martelotto, Timour Baslan, Alberto Vides, Martha Solomon, Todd Hembrough

Nat Med· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tumours with class 3 BRAF mutants are sensitive to the inhibition of activated RAS.
Zhan Yao, Rona Yaeger, Vanessa S Rodrik-Outmezguine, Anthony Tao, Neilawattie M Torres, Todd Hembrough

Nature· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Proof of the quantitative potential of immunofluorescence by mass spectrometry.
Maria I Toki, Fabiola Cecchi, Todd Hembrough, Konstantinos N Syrigos, David L Rimm

Lab Invest· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis